2013-07-05T15:30:53-07:00 2012-08-31 990 2011-09-01 953771980 Barlow Group BARL 2132504200 2000 Stadium Way Los Angeles CA 90026 Ed Engesser 2013-07-05 2011 2016-02-24 21:20:13Z Ed Engesser 2000 Stadium Way Los Angeles CA 90026 2110420 false false X barlow2000.org X 1994 CA Barlow Group is the parent company for three other 501c3 organizations, Barlow Respiratory Hospital, Barlow Foundation and Barlow Research Center. The Barlow Group owns and manages an investment portfolio that is used to provide financial support for its affiliated entities. During 2011 and in recent years the Barlow Group has focused on accumulating funds to support the construction of a new hospital to replace the current facility that was constructed in 1927. The estimated cost to construct and equip this new hospital is $105,000,000. Due to Barlow Respiratory Hospital's limited resources, the Barlow Group's resources will be a critical source of funding for the new hospital. During 2011 and the past few years, Barlow Group's assets have grown to a level that will hopefully be sufficient to enable the new hospital to be constructed. 10 9 0 0 0 0 2179636 2110420 0 2179636 2110420 0 0 0 0 0 216162 201073 216162 201073 1963474 1909347 37487605 41462398 127152 141302 37360453 41321096 Barlow Group is the parent company for three other 501c3 organizations, Barlow Respiratory Hospital, Barlow Foundation and Barlow Research Center. The Barlow Group owns and manages an investment portfolio that is used to provide financial support for its affiliated entities. During 2011 and in recent years the Barlow Group has focused on accumulating funds to support the construction of a new hospital to replace the current facility that was constructed in 1927. The estimated cost to construct and equip this new hospital is $105,000,000. Due to Barlow Respiratory Hospital's limited resources, the Barlow Group's resources will be a critical source of funding for the new hospital. During 2011 and the past few years, Barlow Group's assets have grown to a level that will hopefully be sufficient to enable the new hospital to be constructed. false false Barlow Group is the parent company for three other 501c3 organizations, Barlow Respiratory Hospital, Barlow Foundation and Barlow Research Center. The Barlow Group owns and manages an investment portfolio that is used to provide financial support for its affiliated entities. During 2011 and in recent years the Barlow Group has focused on accumulating funds to support the construction of a new hospital to replace the current facility that was constructed in 1927. The estimated cost to construct and equip this new hospital is $105,000,000. Due to Barlow Respiratory Hospital's limited resources, the Barlow Group's resources will be a critical source of funding for the new hospital. During 2011 and the past few years, Barlow Group's assets have grown to a level that will hopefully be sufficient to enable the new hospital to be constructed. true false false false false false false false false true false false false true true true false true false false false false false false false false false false false true false false false false false false false false false false false false false false false false true false false false false true 0 0 false 0 false false false false false false false false false false false false 0 false false false false false false false false false false false X 10 9 false false false false false false false true true false true true true true true true true true false false false false CA X Ed Engesser 2132504200 2000 Stadium Way Los Angeles CA 90026 Ann Van Dormolen 1.00 X 0 0 0 Carrie Brillstein 1.00 X 0 0 0 Bradford Bolger 1.00 X 0 0 0 Diane Naegele 1.00 X 0 0 0 Eric Kleerup MD 1.00 X 0 0 0 Frederic Rheinstein 1.00 X 0 0 0 Jason Zayon 1.00 X 0 0 0 Margaret Crane 1.00 X X 0 260242 19376 Michael Berger 1.00 X 0 0 0 Richard Seiden 1.00 X 0 0 0 Ed Engesser 3.00 X 0 206580 30702 466822 50078 0 false true false Merrill Lynch 100 Wilshire Blvd suite 1325 Santa Monica CA 90401 investment services 202221 1 0 0 820253 820253 0 0 0 1290167 1290167 1290167 1290167 0 0 0 0 2110420 1290167 820253 0 0 0 0 0 0 0 0 0 0 11000 11000 0 0 0 0 189895 189895 0 0 0 0 0 0 0 0 0 0 0 0 0 178 178 0 201073 0 201073 0 1045 1098 0 0 0 0 0 0 0 16922 0 30186203 33425727 0 0 0 7300357 8018651 37487605 41462398 3130 127152 138172 127152 141302 X 29885096 33127445 2412578 2377616 5062779 5816035 37360453 41321096 37487605 41462398 X 1909347 2051296 X false true true X false false X X false false false Barlow Research Center 954560786 4 true true true 0 Barlow Foundation 954560787 7 true true true 0 Barlow Respiratory Hospital 951647809 3 true true true 0 3 7475357 752238 33944 8193651 6855277 640416 20336 7475357 6566530 308445 19698 6855277 false false false Equity in assets of charitable remainder 8018651 8018651 Due to affiliates 138172 138172 Part X Part X : FIN48 Footnote The Group has been determined to be exempt organizations by the Internal Revenue Service and the California Franchise Tax Board and generally are not subject to taxes on income pursuant to Section 501(c)(3) and Section 23701(d) of the Internal Revenue Code and California Revenue and Taxation Code, respectively. In addition, the Group is recognized as a public charity (not a private foundation) under Sections 509(a)(1)/170(b)(1)(A) of the Internal Revenue Code. Part XI, Line 8 Part XI, Line 8: Other Changes in Net Assets or Fund Balances Increase in permanently restricted net assets $753256 Decrease in temporarily restricted net assets $ -34962 Part V, Line 4 Part V, Line 4: Intended uses of the endowment fund. Used to support activities of Barlow Respiratory Hospital, Barlow Foundation and Barlow Research Center false false false false false false false false false false Margaret Crane 250242 10000 6212 13164 279618 Ed Engesser 196580 10000 6277 24425 237282 Form 990,Part VII,Section A,1aColumn(E) Name and Title Average hours per week devoted to related organizationsMargaret CranePresident & CEO 40Eric Kleerup, MD.Director 1Ed Engesser CFO 40 Form 990, Part VI, Line 19 Form 990, Part VI, Line 19: Other Organization Documents Publicly Available The audited financial statements, governing/organizing documents, and conflict of interest policy are all available upon request. Form 990, Part VI, Line 12c Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts A Code of Conduct has been developed and is reviewed and an affirmation statement is signed annually. In addition a "Conflict of interest Board of Directors" Policy is reviewed and a "Conflict of Interest Disclosure Questionnaire" is completed every two years. Form 990, Part VI, Line 11 Form 990, Part VI, Line 11: Form 990 Review Process The Chief Financial Officer and the Finance Department staff will prepare and file the returns. When it is deemed appropriate, consultative support and /or review will be solicited from an external public accounting firm. Prior to filing, the return for each of the Barlow Organizations will be distributed to the Audit Committee of the Barlow Group Board of Directors for their review. The Chief Executive Officer performs a final review and approves the Annual Information Returns before filing. Barlow Research Center 2000 Stadium Way Los Angeles CA 90026 954560786 Scientific & medical research CA 501c3 4 N/A false Barlow Foundation 2000 Stadium Way Los Angeles CA 90026 954560787 Fundraising CA 501c3 7 N/A false Barlow Respiratory Hospital 2000 Stadium Way Los Angeles CA 90026 951647809 Long-term cute care hospital CA 501c3 3 N/A false false false false false false false false false false false false false false true false false false false Barlow Respiratory Hospital n 516900 actual expense